PLX

Tear Duct Occluder

Product code
PLX
Device name
Tear Duct Occluder
Device class
Class 1
21 CFR
21 CFR 886.5838
Medical specialty
Ophthalmic
Marketing pathway
510(K) Exempt
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A nasolacrimal compression device is a device used to compress the nasolacrimal ducts to reduce drainage by means of temporary occlusion of the nasolacrimal system. The device may include a nose piece attached to a frame to apply pressure to the duct.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: PLX
Classification and pathway per current FDA publications. Data from openFDA (CC0).